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CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW 
Mammals are constantly exposed in their environment to a vast array of 
chemicals that are foreign to their bodies, the so-called xenobiotics. These 
foreign chemicals, or xenobiotics, can be of natural origin such as flavonoids, 
monoterpenes, diterpenes and sesquiterpene lactones which are prevalent in 
fruits, vegetables, and forage-plants or they can be man-made such as drugs, 
food additives, cosmetic ingredients, and environmental-pollutants . 
. Xenobiotics enter the mammalian body and represent a potential threat 
to the individual. Fortunately, mammalian cells have a variety of enzymatic 
processes capable of detoxifying foreign chemicals. Detoxification is achieved 
by converting xenobiotics into more water-soluble metabolites, thus restricting 
their ability to partition into biological membranes or to be reabsorbed; and 
consequently, facilitating their excretion and elimination from the body. The 
hydrophilicity conferred upon these xenobiotics is the sequel of an enzymatic 
process called biotransformation. 
Biotransformation is the sum of two integrated phases by which a 
xenobiotic is subjected to chemical modification resulting in most cases in 
production of metabolites that are more polar and less lipotropic i.e. can be 
more readily excreted. However, it should be emphasized that in some 
1 
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instances biotransformation can lead to generation of dangerous electrophiles 
that are even more toxic than the parent compound. This is particularly true 
for some chemical carcinogens and organo-phosphorous insecticides 
(Guengrich, 1991). 
Phase I biotransformation reactions involve oxidation, reduction and 
hydrolysis. Many oxidation and reduction (Redox) reactions are catalyzed by 
cytochrome P-450 or flavin monooxygenase; a prime function of redox 
reactions is the addition of functional groups such as OH, SH, NH2, and COOH 
to the original compound, thereby rendering it more water-soluble. Hydrolytic 
reactions are catalyzed by hydrolases, esterases, and amidases; a prime 
function of hydrolysis is the exposure of a pre-existing functional group. 
Phase II biotransformation reactions involve the covalent linkage of 
xenobiotics or phase I-derived metabolites to an endogenous hydrophilic moiety 
producing a conjugate. In this case, the endogenous moieties are glucuronic 
acid, sulphate and amino acids. Conjugation of xenobiotics promotes their 
ionization at physiological pH, and thus facilitates their excretion through biliary 
and renal routes (Sipes and Gandolfi, 1991 ). 
Having delineated the biphasic nature of biotransformation, it is worthy 
to note that there are numerous factors affecting these reactions, such as 
nutritional status, age, route of administration, dose, time of the day, sex, 
disease status, and enzyme induction or inhibition (Sipes and Gandolfi, 1991). 
Dietary Influences on Biotransformation 
Many dietary factors have the potential for markedly affecting 
biotransformation. 
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For instance, increased dietary protein enhances 
biotransformation of drugs as well as hydroxylation of endogenous steroids 
(Kappas et al., 1983). Meat eaters have more rapid antipyrine clearance as 
compared to vegetarians (Campbell and Hayes, 1974; Kappas et al., 1976, and 
Mucklow et al., 1982). Conversely, birds kept on a low-protein diet have 
manifested an impairment in biotransformation of malaoxon, a desulfurated 
metabolite ofthe insecticide malathion. Consequently, protein deficiency tends 
to increase malathion toxicity (Ehrich et al., 1984). 
Vitamins are other essential dietary constituents that play a pivotal role 
in maintaining the activity of hepatic biotransformation reactions. For instance, 
deficiency of vitamins A,C, and E has been reported to lower the level of 
cytochrome P-450 and consequently compromise the biotransformation 
efficiency of the Mixed Function Oxidase system. (Colby et al., 1975; Zannoni 
et al., 1973; Horn et al., 1976). In contrast, administration of vitamin C 
(ascorbic acid) or E (a-tocopherol) has been reported to enhance hydroxylation 
reactions in phase I biotransformation (Zannoni et al., 1973; Horn et al., 1976). 
Other examples illustrating the significant role of dietary chemicals and 
nutrients in modulating biotransformations are the effects of indoles, 
flavonoids, and various alkaloids present in plants. lndoles, prevalent in 
cruciferous vegetables such as brussels sprouts and cabbage, are potent 
inducing agents as attested to by the significant increase in antipyrine clearance 
in patients fed brussels sprouts and cabbage (Pantuck et al., 1979). 
Flavonoids, prevalent in citrus fruits, have been reported to increase the in vivo 
and in vitro metabolism of zoxazolamine to 6-hydroxyzoxazolamine in neonatal 
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rats. (Lasker et al., 1984). Similarly, the presence of methylxanthine and 
caffeine alkaloids in several plant families such as Aquifoliaceae, Rubiaceae, 
Sterculiaceae and Theaceae can lead to a remarkable increase in hepatic 
hydroxylation and 0-demethylation (Mitoma et al., 1968; Fraser et al., 1977). 
Thus, ingestion of plants belonging to these families could be expected to 
hasten elimination of concurrently administered drugs. 
Limited studies in rats indicate that pyrrolizidine alkaloids (PA) either in 
whole plant such as in Senecio jacobaea "Tansy ragwort" or purified such as 
seneciphylline, an extract from Senecio vulgaris, are capable of inducing hepatic 
epoxide hydrolase and glutathione-s-transferase when administered in the diet 
(Miranda et al., 1980; Kakrani and Kalyani, 1984). 
Modulation of biotransformation produced by chemicals of plant origin 
may also be an important factor in exacerbation of toxicant effects. A prime 
example of interest in sheep is seen with ingestion of Tetradymia glabrata 
(horse brush). When it is preceded by ingestion of Artemisia nova (black sage 
brush), an overwhelming photosensitization occurs which is not otherwise a 
problem when Tetradymia is eaten alone. (Jennings et al., 1978; Johnson, 
1978). This example underscores the role of Artemisia as a preconditioning 
plant and its ability to aggravate the hepatotoxicity exerted by Tetradymia 
ingestion. In fact, Artemisia nova was thought to be a potent inducer of the 
Mixed Function Oxidase (MFO) system. This hypothesis was extrapolated from 
an experiment done in mice where pretreatment with prototype inducers such 
as phenobarbital or 3-Methylcholanthrene caused death to ensue more quickly 
when the mice were challenged with tetradymol, a furanoeremophilane, 
5 
extracted from Tetradymia. The reverse was true when the mice were 
pretreated with classical inhibitors such as SKF-525A or piperonyl butoxide and 
then challenged with tetradymol. In the latter case, mice were able to survive 
longer as the death time increased significantly from a control of 7 hours to 1 7 
hours (Jennings et al., 1978). These results from mice and those from a series 
of experiments conducted in sheep by Johnson ( 1978), in which he described 
the synergism between Artemisia and Tetradymia that facilitates development 
of the clinical syndrome "bighead," have reinforced the hypothesis that 
Artemisia exacerbates Tetradymia toxicity by inducing the Mixed Function 
Oxidase System. 
Having discussed the stimulatory-type effect of several plants and plant 
chemicals, it would be of importance to consider plants and plant chemicals 
that exhibit an inhibitory-type effect such as piperine alkaloids, naringin, and 
sesquiterpene lactones from the pepper family, citrus fruits, and sunflower 
family, respectively. 
Piperine, a major alkaloid found in green and red peppers, has been 
reported to inhibit UDP-glucuronyltransferase, an essential enzyme in Phase II 
biotransformation, leading to a decrease in the rate of glucuronidation (Sing et 
al., 1986). As a sequel of this inhibition, there is a delay in the metabolic 
conversion of compounds that require glucuronic acid conjugation. Conseq-
uently, piperine tends to prolong the residence time of drugs in the body. This 
phenomenon would be even more prominent in drugs that are directly 
glucuronidated without undergoing phase I biotransformation; for instance, 
phenylbutazone which is used in treatment of rheumatic diseases (Aarbakke et 
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al., 1977) and tripelennamine, an antihistaminic drug (Chaudhuri et al., 1976). 
Naringin, an abundant natural flavonoid in grapefruit, was found to inhibit 
a specific isozyme within the cytochrome P-450 superfamily called (CYP3A4). 
Therefore, Naringin could be used in cancer chemoprevention in situations 
where the carcinogen requires bioactivation by the same isozyme. For 
instance, aflatoxins are not active per se but require bioactivation, mediated 
through the isozyme CYP3A4, in order to produce culprit epoxides that bind 
covalently to DNA forming adducts; thus, Naringin is used in blocking 
bioactivation of aflatoxins into reactive intermediates (Guengrich and Kim, 
1990). 
Sesguiterpene lactones Sesquiterpene lactones are characteristic components 
of the ubiquitous plant family Compositae (sunflower). Helenalin, hymenoxon 
and flexuosin are structurally related sesquiterpene lactones which have been 
isolated from Helenium microcephalum "small head sneeze weed", Hymenoxys 
odorata "western bitter weed", and Helenium flexuosum, respectively. (Herz, 
1973; Herz, 1978; Kim et al., 1987). Sesquiterpene lactones are defined 
chemically as 1 5 carbon atom cyclic esters. These sesquiterpene lactones owe 
their toxicity to the presence of a highly reactive a-methylene-y-lactone moiety, 
which acts as an electrophile that can alkylate thiol groups of biological 
nucleophiles through a Michael-type reaction (Kupchan, 1970; Merrill et al., 
1986). Therefore, the chemical reactivity of these sesquiterpene lactones can 
potentially disrupt a number of metabolic pathways necessary for homeostasis. 
For example, phosphofructokinase, an essential allosteric enzyme that controls 
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the pace of the glycolytic pathway, was found to be inhibited by sesquiterpene 
lactones (Hanson et al., 1970). 
Elissalde and Ivie in ( 1 987) have reported that sesquiterpene lactones 
alkylate thiol groups of adenylate cyclase rendering it incapable of hydrolyzing 
pyrophosphate from an ATP molecule; thus, disrupting generation of cyclic 
AMP. Cyclic AMP is a known intracellular second messenger for many 
hormones and disruption of its production, because of deactivation of adenylate 
cyclase by sesquiterpene lactones, could negatively alter cellular com-
munication. 
Sesquiterpene lactones are also capable of depleting hepatic glutathione 
(Merrill et al., 1988) and by so doing they deprive animal cells of the beneficial 
effects of reduced glutathione (GSH), which acts as a sulfhydryl buffer against 
hydrogen peroxide and organic peroxides. 
Numerous sesquiterpene lactones bearing an a-methylene-y-lactone 
group have been isolated and characterized as having an antitumor activity. For 
instance, helenalin and tenulin have been reported by Lee et al. ( 1977) to act 
as suppressors of Ehrlich ascites tumors in CF1 male mice. This suppression 
is achieved by inhibition of DNA synthesis and DNA polymerase enzymatic 
activities. Another example of interest would be Damsin, the major 
sesquiterpene lactone isolated from Ambrosia maritima, the antitumor activity 
of which has been assayed under the auspices of the Cancer Chemotherapy 
National Service Center (CCNSC) and which has been used as a reference 
standard for antitumor activities (Doskotch and Hufford, 1969). 
Several plants belonging to the genus Artemisia, a genus in the family 
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Compositae, have also been reported to contain sesquiterpene lactones. For 
example, Artemisia genipi was reported by Appendino et al. ( 1982) as a source 
of sesquiterpene lactones such as artemorin, santamarine, and reynosin. This 
plant is used extensively by liqueur-producing industries in Italy to produce a 
liqueur called "Genipi." Another interesting species, Artemisia herba-alba, a 
widespread plant of the desert of lr~q known as Shih (Arabic name), has been 
reported as a panacea for treatment of diabetes mellitus (Al-waili, 1 986) 
Interestingly, plant concoctions are not only capable of reducing elevated blood , 
sugar but also capable of treating diabetics who are considered non-responsive 
to conventional oral antidiabetic therapy. The plant concoctions are apparently 
quite popular in Iraq, where they are sold in markets. 
A unique antimalarial sesquiterpene lactone, Artemisinin, has been 
isolated from the leafy portions of the chinese herb Artemisia annua. 
Artemisinin, known in Chinese language as Oinghaosu, has been used 
successfully in treatment of cerebral malaria, a pernicious malaria that leads to 
coma when more than 5% of the erythrocytes are parasitized by Plasmodium 
falciparum (Klayman, 1985). 
Cytochrome P-450 
The most important and predominant enzyme system involved in Phase 
biotransformation is cytochrome P-450, a major component of the Mixed 
Function Oxidase (MFO) system, which acquires its name from the fact that 
when the reduced cytochrome P-450 forms a ligand with carbon monoxide, 
the maximal absorbance of light occurs at 450 nm and hence the name 
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cytochrome P-450 (Sipes and Gandolfi, 1991 ). 
In cytochrome P-450 catalyzed reactions, the substrate combines with 
the oxidized form of cytochrome P-450 (Fe3 +) to form a substrate-cytochrome 
P-450 Complex. This complex then accepts an electron from NADPH (via 
NADPH-cytochrome P-450 reductase) and by so doing the iron in the 
cytochrome P-450 heme moiety is reduced (Fe2 +). The reduced substrate-
cytochrome P-450 complex subsequently combines with molecular oxygen, 
which then accepts another electron from NADPH. The two electrons donated 
by NADPH are transferred to molecular oxygen resulting in the creation of a 
highly reactive oxygen species. One atom of this reactive oxygen is inserted 
into the substrate to yield an oxygenated substrate, while the other atom is 
reduced to water. The oxygenated substrate then dissociates from the 
complex to facilitate regeneration of the oxidized form of cytochrome P-450 
and thus perpetuates its catalytic cycle (Guengrich and MacDonald, 1990). 
In some cases, the second electron is donated by NADH instead of 
NADPH (via NADH-cytochrome b5 reductase). For example, the catalysis of the 
0-demethylation of P-nitroanisole requires cytochrome b5 as an obligatory 
hemoprotein which facilitates donation of the second electron (Miki et al., 
1980). 
Nomenclature of P-450 Superfamily 
Numerous nomenclatures have been used to identify the different 
isozymes of cytochrome p-450. Originally, it was assumed that catalytic 
activities would help researchers in the assignment of the orthologous isozyme 
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genes across species; orthologous gene in two species refers to an ancestral 
gene that existed before the evolutionary divergence of the two species (Nebert 
et al., 1 989). This assumption is no longer valid since it has been shown that 
a single amino acid difference in a cytochrome P-450 peptide of about 500 
amino acids can be critical in changing the catalytic activity (Nebert et al., 
1991). For this reason, old nomenclatures of cytochrome P-450 based on 
catalytic activities were discouraged and a new nomenclature based on amino 
acid similarities and gene mapping was adopted (Nebert et al., 1991) 
Currently, the cytochrome P-450 superfamily is believed to be composed 
of 1 0 families that comprise 1 8 subfamilies; each subfamily appears to 
represent a cluster of tightly linked genes. The adopted nomenclature 
recommended the use of an italicized root symbol "CYP" for human and "cyp" 
for mice denoting cytochrome P-450. This root symbol is to be followed by an 
Arabic number denoting the family, then a letter designating the subfamily (if 
two or more genes exist within the subfamily, then again an Arabic numeral 
should follow the preceding letter to represent the individual gene). For 
example, on the basis of amino acid similarities, the orthologous genes CYP1 A 1 
and CYP1 A2 were found to exist in human, mouse, rat, rabbit, hamster, dog 
and monkeys and they were inducible by polycyclic aromatic hydrocarbons 
such as 3-methylcholanthrene. These two orthologous genes are conserved 
across species lines, except in trout. Trout appear to lack the CYP1 A2 gene 
(Nebert et al., 1991 ). It is worthy to mention that these two genes were 
referred to in the older literature as cytochrome P-448. On the other hand, 
certain subfamilies of cytochrome P-450 enzyme are inducible by phenobarbital 
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such as CYP28, CYP2C, and CYP3A (Nebert et al., 1991). 
Statement of Dissertation Objectives 
The existing problematical issue in veterinary toxicology is the variety 
of chemical compounds present in plants which represent the sole source of 
food for large animals. These chemical compounds may act as inducers or 
inhibitors of drug biotransformation. Thus, leading to attenuation or 
amplification of biological responses to concurrently administered drugs. 
The purpose of the first part of this study was to assess the impact of 
feeding Artemisia on the disposition of concurrently administered drugs in 
sheep. Artemisia was selected because it is a common range plant in western 
Oklahoma. Moreover, in addition to its purported value as a forage plant, there 
is some evidence suggesting that ingestion of Artemisia tends to enhance the 
expression of the hepatotoxicant effects exerted by Tetradymia ingestion. 
(Johnson, 1978; Jennings et al., 1978). This phenomenon indicates that 
Artemisia plays a synergistic role in the development of the clinical 
photosensitization syndrome "bighead". From that standpoint, Artemisia is 
intriguing as a possible modulator of biotransformation of concurrently 
administered drugs. To assess that possibility, sheep were administered 
antipyrine and erythromycin under two dietary regimens, one under a control-
dietary regimen and the other under a regimen containing Artemisia. 
Subsequently, the disposition of drugs under the two dietary regimens were 
compared. 
The purpose of the second part of this study was to determine the effect 
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of adding Artemisia or Helenium to the diet on the disposition of antipyrine in 
rabbits. The results of these studies will shed light on the role of dietary 
constituents as an important determinant of drug biotransformation and 
disposition. 
The purpose of the third part of this study was to determine the effect 
of feeding Artemisia or Helenium on the activity of hepatic cytochrome P-450, 
an essential enzyme component of the Mixed Function Oxidase System (MFO) 
that mediates catalysis of xenobiotics in phase I biotransformation. In addition, 
the 0-dealkylation of a series of alkoxyresorufin ethers by hepatic microsomes 
prepared from control-fed rabbits and plant-fed rabbits were investigated in 
order to gain further insights up to the level of isozymes within cytochrome P-
450. Known inducers or inhibitors of cytochrome P-450 isozymes were used 
to provide a wide facet for comparison between dealkylation conferred by 
hepatic microsomes prepared from plant-fed rabbits versus dealkylation by 
microsomes prepared from other xenobiotic-treated rabbits. 
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CHAPTER II 
EFFECTS OF FEEDING ARTEMISIA SPP. ON DISPOSITION OF 
ANTIPYRINE AND ERYTHROMYCIN IN SHEEP 
INTRODUCTION 
There are many dietary components including proteins, minerals, and 
vitamins that can modulate xenobiotic or drug biotransformation. Not the least 
of these components are the naturally occurring chemicals present in food 
plants which act as inducers or inhibitors of the Mixed Function Oxidase 
System (MFO), a major enzymatic system that mediates biotransformation, and 
as such can lead to attenuation or amplification of biological responses to 
concurrently administered drugs. For example, indoles of the cabbage family 
(Cruciferae) have been reported to act as inducers of MFO; therefore, people 
consuming brussels sprouts and cabbage demonstrated a significant decrease 
in the half-life of concurrently administered antipyrine (Pantuck et al., 1979 and 
1 984). In contrast, rats and mice fed trans-anethole or myristicin of anise 
seeds and nutmeg, respectively, exhibited a remarkable prolongation of 
pentobarbital sleeping time indicating an inhibitory-type effect on MFO (Marcus 
and Lichtenstein, 1982). 
A prime example of considerable interest in sheep is the apparent 
17 
18 
biotransformation effect observed with ingestion of Tetradymia (horse brush) 
when it is preceded by ingestion of Artemisia (sage brush). In such instances, 
an overwhelming hepatic photosensitization and a remarkable serum enzyme 
elevation (GOT and LDH) occur which are not otherwise a problem when 
Tetradymia is eaten alone. This phenomenon indicates that Artemisia acts as 
a preconditioning or predisposing factor that tends to aggravate the 
hepatotoxicity exerted by Tetradymia ingestion (Jennings et al., 1978; Johnson 
1 978). From that standpoint, Artemisia is intriguing as a possible modulator 
of biotransformation of concurrently administered drugs. 
In the present experiment the impact of feeding Artemisia filifolia (sand 
sagebrush), Artemisia ludoviciana (white sage), and Medicago sativa (alfalfa) 
on disposition of antipyrine and erythromycin were investigated. Alfalfa was 
added as a positive control since it has been reported to induce aryl 
hydrocarbon hydroxylase activity (Hendrich and Bjeldane, 1983). Antipyrine 
was selected because of its general acceptance as a model drug for indirect 
assessment of Mixed Function Oxidase (MFO) activity. (Vesell, 1979; Danhof 
and Teunissen, 1984). Antipyrine gained this popularity due to its many 
favorable characteristics including minimal plasma protein binding, and total 
dependence on hepatic MFO activity for biotransformation and elimination. 
Therefore, an alteration in antipyrine half-life is considered to be an indirect 
index for assessment of MFO activity. Typically, compounds known to induce 
MFO in the liver tend to shorten the plasma half-life of antipyrine whereas 
compounds known to inhibit MFO tend to prolong the plasma half-life of 
antipyrine (Baggot, 1 977). Erythromycin was selected because it is a 
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commonly used antibiotic in veterinary practice; in addition, to its requirement 
for N-dealkylation and biotransformation. (Burrows, 1980) 
MATERIALS AND METHODS 
Experimental Protocol 
Six white-face ewes, ranging in weight from 43-73 kg, were divided into 
3 pairs. Each pair were housed in a separate pen. All animals were in apparent 
good health, maintained on a control diet of grass hay and concentrates, and 
allowed free access to water. 
The experiment was carried out in three periods, each period composed 
of two phases (control-diet phase and test-diet phase). An interval of one 
month was allowed between experimental periods in order to avoid the 
possibility of residual or carry-over effect of a treatment into the following 
period. The purpose of the three periods was to permit each pair's diet to be 
changed to include one of the three test plants; thus each animal was tested 
under the influence of each of the three test diets. 
In the first week of each period of the experiment (Control-diet phase), 
all six ewes were acclimated and maintained on the control diet. On days 5 
and 7 of the first week, antipyrine and erythromycin were administered in a 
crossover-type design at a dose rate of 15 mg/kg i.v. On day 5, one animal 
from each pair received antipyrine while the other received erythromycin. On 
day 7, the two test drugs were reversed for the pair. Blood samples for drug 
assay were collected at 1,2,4,6,8, 10, and 12 hours after drug administration. 
Serum was harvested and stored at -20°C until assayed. 
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In the second week of each period of the experiment (test-diet phase), 
each pair were fed a test plant (either Artemisia filifolia, Artemisia ludoviciana 
or alfalfa) in combination with grass hay and concentrates. In a similar fashion 
to the control-diet phase, antipyrine and erythromycin were administered on 
days 5 and 7. Blood samples for drug assay were collected, serum was 
harvested and kept frozen as described previously. 
Drugs Assay 
(i) Antipyrine 
Antipyrine concentrations in serum were quantitated using a gas 
chromatographic method reported by Clarke et al. ( 1 989 and 1 992). Forty 
microliter of 5N NaOH and 2 ml of ethyl acetate (containing 2.5 µg/ml of 
phenacetin as an internal standard) were added in sequence to 250 µL of the 
sample. The sample was then vortexed for 30 seconds to assure extraction 
uniformity. The combination was centrifuged at 600 g for 15 minutes. 
Aliquots of the supernatant ( 1 . 5 ml) were transferred to clean test tubes and 
evaporated to dryness under nitrogen. The resultant precipitate was 
redissolved in 250 µL of hexane. Antipyrine standards ( 1, 2. 5, 5, 10, 25, and 
50 ppm) were prepared by dissolving appropriate amounts of antipyrine in 250 
µL of blank sheep serum. These standards were subjected to the same 
extraction and analytical procedures as the test sera. Antipyrine concentrations 
were quantitated by injecting 4 µL aliquots of the extracted sample, dissolved 
in hexane, into a gas chromatograph (Model 565, Tracor Instruments Austin 
Inc., Austin, Tx, U.S.A.) with a 6-foot, 2-mm ID, 1 /4-inch OD glass column 
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packed with GP 3%, SP-2250-DB on 100/120 supelcoport (Supelco Inc., 
Bellefonte, PA, U.S.A.). The temperature of the column, injection port, and 
nitrogen-phosphorous detector (Model 702, Tracor Instruments Austin Inc.) 
were adjusted to 180, 230, and 250oC, respectively. Flow rate for helium 
carrier gas was 25 ml/min; for detector hydrogen, 2.5 ml/min; and for air, 120 
ml/min. Peak heights were measured and recorded using an integrator (Model 
SP4290, Spectra-physics, San Jose, CA, U.S.A.). Ratios of the standard peak 
heights were correlated with their corresponding known concentrations in order 
to establish the linear regression equation or the so-called deterministic 
equation (Y = mX + c). Unknown concentrations of the sample sera (Y's) 
were calculated using the pre-established deterministic equation. 
(ii) Erythromycin 
Erythromycin serum samples were bioassayed by an agar-well diffusion 
method, employing Micrococcus luteus ATCC 9341 as the test organism 
(Bennett et al., 1966). Standard solutions were prepared in sheep serum by 
appropriate serial dilutions of erythromycin. Inhibition-zone widths were 
measured and correlated with known standard concentrations to establish the 
standard curve. Widths of inhibition-zones from unknown test sera were 
measured and converted to serum concentrations using standard curves 
developed for each 81-well agar plate. 
Pharmacokinetic methods and statistics 
Coefficients and exponents were calculated using an iterative least 
squares non-linear regression analysis computerized program, ESTRIP (Brown 
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and Manno, 1978). The data were best described by a monoexponential 
equation: CP = Be·Pt due to paucity of blood samples collected during the first 
hour post-injection that limited our ability to discern the distribution phase. 
The following pharmacokinetic parameters were used for comparisons: 
( 1) The overall elimination rate constant (P) = log-linear slope of disposition 
curve; (2) elimination half-life (ty.p) = 0.693/P; (3) apparent volume of 
distribution (V d) = Dose/8 (where 8 represents the extrapolated zero time 
serum drug concentration); (4) body clearance (Cl8) = PxVd 
Testing of statistical significance was accomplished using the paired 
comparisons between test diets and corresponding control values. The effect 
of test-diets on the slope of drug elimination (P) was tested using paired t-test. 
The non-parametric test, Wilco~on's rank sum, was used to compare the effect 
of test-diets on ty.p, V d• and Cl8 since a normal distribution cannot be assumed 
for those parameters (Powers et al., 1978; Powers, 1990). 
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RESULTS 
This experiment was prematurely terminated due to environmental 
factors. Results reported herein include only the first and second periods of the 
experimental design, the third period was excluded. Therefore, pharmaco-
kinetic variables were calculated for only four sheep per dietary-test plant 
instead of six sheep. Thus, the same four sheep are not represented for each 
diet. Pharmacokinetic variables of controls during the first and second periods 
were not statistically different. 
The effects of various diets on antipyrine and erythromycin 
pharmacokinetic variables are shown in Table 1 and Table 2, respectively. For 
antipyrine, a significant increase in the slope of elimination (P) and a marked 
decrease in half-life (ty.p) were observed when the sheep diet was changed from 
grass hay and concentrates to any one of the three test plants in combination 
with grass hay and concentrates. Antipyrine volume of distribution (V d) 
remained unchanged during the different dietary regimens. The relevant 
increase in the slope of elimination (P) in the presence of a constant volume of 
distribution (Vd) resulted in an increase in clearance (Cl8 = P x Vd). Clearance 
increased approximately two fold during diets containing Artemisia species or 
alfalfa as compared to control diet. 
With regard to erythromycin, there were no significant changes among 
pharmacokinetic variables in response to dietary supplementation with either 
Artemisia filifolia, Artemisia ludoviciana or alfalfa. 
Table 1. 
MEAN OR MEDIAN PHARMACOKINETIC VALUES FOR ANTIPYRINE ( 15 mg/kg) 
IN SHEEP FED WITH DIFFERENT SPECIES OF ARTEMISIA. 
Diet Pharmacokinetic Value 
p*min-1 ty.p tmin Vdtml/kg Cl8 tml/min/kg 
Control diet 0.0051 ± 0.0015A 137 ± 36A 1010 ± 130A 5.2 ± 1.1A 
Artemisia filifolia 0.0096 ± 0.00238 78 ± 158 1090 ± 132A 9.8 ± 1.38 
Control diet 0.0050 ± 0.0018A 132 ± 32A 1018 ± 125A 5.1 ± 1.1A 
Artemisia ludoviciana 0.0106 ± 0.00198 67 ± 9B 1160 ± 45A 10.3 ± 0.98 
Control diet 0.0049 ± 0.0013A 138 ± 34A 1012 ± 122A 4.8 ± 1.2A 
Alfalfa diet 0.0115 ± 0.0031 8 60 ± 9B 970 ± 68A 10.7 ± 1.78 
*Mean ± SD 
tMedian ± Median deviation (Median deviation = ~ I xi - xml) 
n 
In comparison of different diets to the control diet means or medians within a column with different 
superscriptsA or 8 are significantly different from each other ( P < 0.05) using paired-t-test or 




MEAN OR MEDIAN PHARMACOKINETIC VALUES FOR ERYTHROMYCIN (15 mg/kg) 
IN SHEEP FED WITH DIFFERENT SPECIES OF ARTEMISIA 
Diet Pharmacokinetic Value 
P*min·1 ty,p tmin vd tml/kg Cl8 tml/min/kg 
Control diet 0.0064 ± 0.0015A 105 ± 18A 1427 ± 240A 10.4 ± 1.5A 
Artemisia filifolia 0.0058 ± 0.0013A 113 ± 20A 1375 ± 208A 10.2 ± 2.7A 
Control diet 0.0063 ± 0.0018A 100 ± 12A 1410 ± 215A 10.3 ± 1.4A 
Artemisia ludoviciana 0.0067 ± 0.0020A 113 ± 15A 1334 ± 253A 10.1 ± 1.4A 
Control diet 0.0065 ± 0.0012A 103 ± 15A 1352 ± 196A 9.8 ± 1.7A 
Alfalfa diet 0.0066 ± 0.0017A 108 ± 21A 1286 ± 162A 10.7 ± 1.8A 
*Mean ± SD 
tMedian ± Median deviation (Median deviation = ~ I Xi - Xml) 
n 
In comparison of different diets to the control diet means or medians within a column with different 
superscripts A or 8 are significantly different from each other (P< 0.05) using paired t-test or 





The present studies demonstrated that ingestion of a diet containing 
approximately 2% Artemisia for a week resulted in statistically significant 
changes for antipyrine pharmacokinetic variables. Thus, indicating the potential 
for such a diet to increase the metabolism of antipyrine. Conversely, there was 
little or no change in the metabolism of erythromycin. Thus, it appears that the 
requisite biotransformation pathways for antipyrine and erythromycin differ. 
The pathway for antipyrine biotransformation is mainly via hydroxylation and 
carboxylation {Tufenkji et al., 1988; Witkamp et al., 1991) which are catalyzed 
by the isozyme CYP28, an isozyme within cytochrome P-450 superfamily 
(Bachmann et al., 1991 ). In the case of erythromycin, the biotransformation 
pathway is mainly via N-demethylation which is catalyzed by the isozyme 
CYP3A (Pineau et al., 1990). Therefore, it could be deduced from the present 
studies that Artemisia is capable of exerting an inducing-type effect on the 
isozyme CYP2B but not CYP3A as reflected by the increased metabolism of 
antipyrine while erythromycin metabolism remained unchanged. 
This experiment showed that both Artemisia species as well as alfalfa 
decreased antipyrine half-life (t'hp) and increased its clearance and elimination, 
presumably as a result of inducing Mixed Function Oxidase System (MFO) or 
at least inducing some isozymes within MFO system. This finding may explain 
the increased toxicity and photosensitization seen when Tetradymia ingestion 
is preceded by Artemisia ingestion. In essence, Tetradymia contains tetradymol 
which is further metabolized by the MFO system into culprit intermediates that 
are even more toxic than the parent compound i.e. lethal synthesis or 
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bioactivation (Jennings et al., 1978). Therefore, since Artemisia induces MFO, 
its ingestion would expedite the process of lethal synthesis or hasten the 
conversion of tetradymol into more deleterious intermediates. 
The results of this study indicate that ingestion of plants such as 
Artemisia may have a marked effecton disposition of concurrently administered 
drugs as exemplified by antipyrine. This would be even more important when 
chemicals of greater toxicological impact are used concomitantly. For example, 
insecticides such as Diazinon and parathion are converted in the animal body 
by MFO into harmful metabolites, namely, diazoxon and paraoxon, respectively. 
(Abdelsalam and Ford, 1986; Dikshith, 1991 ). However, in some situations, 
a diet containing Artemisia or alfalfa might augment or increase the 
pharmacological effects of drugs that are not active per se but require 
biotransformation to yield the active metabolites; such as prontosil and 
fenbendazole which are metabolized in the animal body by MFO to yield 
sulfanilamide and fenbendazole sulfoxide, respectively (Yang and Lu, 1987). 
In conclusion, the effects of dietary constituents on the disposition of 
drugs will only be fully appreciated when the underlying mechanisms of 
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CHAPTER Ill 
THE EFFECTS OF ARTEMIS/A FIL/FOL/A AND HELEN/UM FLEXUOSUM ON 
DISPOSITION OF ANTIPYRINE IN RABBITS 
INTRODUCTION 
Humans and animals are exposed on a daily basis to a myriad of 
chemicals present in their food. These chemicals may affect the host directly 
or indirectly through a variety of biological interactions and may act to the 
benefit or detriment of the host. Examples of chemicals in food plants which 
may interact in such a manner are sesquiterpene lactones, sesquiterpene 
alcohols and oxidized matricarins (Geissman and Irwin, 1973) of Artemisia and 
Helenium (Asteraceae). In addition, these plant chemicals may interact with 
those from other ingested plants. For example, Artemisia nova is reported to 
act as a preconditioning plant for toxicity caused by ingestion of Tetradymia 
glabrata. When ingestion of Tetradymia glabrata is preceded by ingestion of 
Artemisia nova, an overwhelming hepatic photosensitization occurs; which is 
not otherwise a problem when each plant is eaten alone (Johnson, 1978). 
Sesquiterpene lactones in Helenium species are well documented livestock 
toxicants (U.S. Department of Agriculture, 1968). In this case, however, both 
direct and indirect effects are apparent. 
The sesquiterpene lactones possess an exocyclic methylene group 
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( = CH2) which is believed to react with thiol-containing compounds by a 
Michael-type addition leading to depletion of reduced glutathione (GSH) 
(Kupchan et al., 1970; Merrill et al., 1988). Reduced glutathione (GSH) is 
formed by reduction of oxidized glutathione (GSSG), a reaction that utilizes 
NADPH as an electron donor (Stryer, 1988). Similarly, cytochrome P-450, a 
major component of Mixed Function Oxidase system, requires NADPH as an 
electron donor to catalyze oxidation of various xenobiotics (Guengrich and 
MacDonald, 1990). Thus, it appears that both GSH and cytochrome P-450 are 
dependent on NADPH as a cofactor. From that standpoint, we hypothesized 
that plants containing sesquiterpene lactones will not only deplete GSH but will 
also affect Mixed Function Oxidase system (MFO) indirectly. 
To evaluate the potential for indirect effects, model drugs for assessing 
hepatic oxidative enzyme activity are useful. Antipyrine has become popular 
for this purpose (Danhof & Teunissen, 1984) because it is distributed evenly 
in total body water with minimal plasma protein binding, and is almost 
exclusively metabolized in the liver by MFO (Vesell, 1979). Therefore, 
compounds known to inhibit MFO in the liver typically prolong the plasma half-
life of antipyrine, and those that induce MFO frequently shorten the plasma 
half-life of antipyrine (Baggot, 1977). 
The purposes of this study were: ( 1) to determine the effects of adding 
Artemisia filifolia or Helenium flexuosum to the diet on antipyrine 
pharmacokinetic parameters as a possible probe for assessment of alterations 
in Mixed Function Oxidase system (MFO)activity, and (2) to evaluate the rabbit 
as an animal model for assessing the impact of xenobiotics in food. 
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MATERIALS AND METHODS 
Two groups of rabbits were used, each group composed of six adult New 
Zealand white male rabbits weighing between 3-4 Kg. Rabbits were caged 
individually in a controlled environment ( 12: 1 2 lighting schedule & temperature 
maintained at 70°F) and allowed to acclimate for a week before treatment 
commenced. Standard rabbit pellets (ACCO) and water were available ad 
libitum. 
The experiments were carried out in series to permit each animal to serve 
as its own control. In the first phase (Control diet) on day 1, all 12 rabbits 
were administered antipyrine into the marginal ear vein at a dose rate of 25 
mg/kg. Blood samples were collected from the contralateral vein at 15, 30, 45, 
60, 90, 120, 180, 240, 300, 360 min after dosing. Serum was harvested and 
kept frozen at -20 C until assayed using a gas chromatographic method (Clarke 
et al., 1992). 
The second phase (test-diet) commenced on day 14, when the six 
rabbits of group 1 were given Artemisia filifolia and the six rabbits of group 2 
were given Helenium flexuosum, in addition to the standard rabbit pellets. The 
air-dried plants were finely ground and given in gelatin capsules at a dose rate 
of 250 mg/kg daily for 5 days. On day 19, each rabbit was again administered 
antipyrine (25 mg/kg) and blood samples were collected using the same 
intervals as those after the first administration during the control diet phase. 
Pharmacokinetic parameters were calculated using mono- or 
biexponential equations by means of an iterative least squares regression 
analysis computer program (Brown and Manno, 1978). The data were best 
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represented by a biexponential equation: Cp = Ae-at + Be-Pt, where Cp is the 
concentration of antipyrine in serum at time t, A and B are intercept terms, and 
a and Pare hybrid rate constants related to distribution and elimination phases, 
respectively. 
The pharmacokinetic parameters: slope of elimination (P) = terminal slope 
of the semilogarithmic plot of serum antipyrine concentration versus time, half-
life of elimination (t¥.ip) = 0.693/P, elimination from central compartment (K81 ) 
= aPIK21 , volume of distribution (Vd) = Dose/AUC.p, and total body clearance 
(Cl8 ) = Dose/AUC0_00 were determined for an open-two compartment model 
with elimination from the central compartment (Gibaldi and Perrier, 1982). 
Statistical analysis 
The variances were determined to be homogenous by the F-test; 
therefore, the student t-test with df(N1 + N2-2) was used to determine the effect 
of the test-diet on the slope of antipyrine elimination (P). The non-parametric 
test, Wilcoxon's rank sum, was used to compare t¥.ip, Vd, K81 and Cl8 since a 
normal distribution cannot be assumed for those parameters (Powers et al., 
1978; Powers, 1990). 
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RESULTS 
There was no significant change in antipyrine pharmacokinetic 
parameters in response to dietary supplementation with Artemisia filifolia as 
shown in table 1 . 
Feeding Helenium flexuosum to rabbits resulted in a significant decrease 
in the slope of antipyrine elimination (P), from a mean of 0.0067min-1 during the 
control diet to a mean of 0.0036 min-1 after feeding the Helenium diet (Table 
1). The sequel of this decrease in the slope of elimination is a marked 
lengthening of half-life (t%p) from a median of 99.5 min (control diet) to a 
median of 215.5 min (Helenium diet). The decay of antipyrine in the serum of 
a representative rabbit during control diet versus a diet containing Helenium is 
shown in figure 1 . This rabbit was selected as a representative of the group 
fed Helenium flexuosum because antipyrine pharmacokinetic variables were 
closest to the median for all rabbits in this group. 
Median elimination rate from the central compartment (K81 ) decreased 
significantly from a median of 0.0245 min-1 (Control diet) to a median of 
0.0084 min-1 (Helenium diet) as shown in table 1. This decrease in the rate of 
elimination from central compartment was not accompanied by a significant 
decrease in total body clearance since there was a significant increase in the 
volume of distribution after feeding Helenium flexuosum. 
Table 1. 
MEAN ± SD OR MEDIAN ± MEDIAN DEVIATION VALUES FOR ANTIPYRINE PHARMACOKINETIC 
PARAMETERS OBTAINED BEFORE AND AFTER FEEDING TEST-DIETS 
CONTAINING EITHER ARTEMIS/A OR HELEN/UM. 
Anti~yrine Anti~yrine 
Control diet Artemisia diet Control diet Helenium diet 
P,min-1 0.0065 ± 0.0017 0.0076 ± 0.016 0.0067 ± 0.0011 0.0036* ± 0.0008 
. t tJ1op,mm 111 ± 21.5 93.5 ± 13.83 99.5 ± 15 215.5** ± 28 
K . -it e1,mm 0.0137 ± 0.0019 0.021 ± 0.006 0.0245 ± 0.005 0.0084** ± 0.0007 
Vd, ml/kg t 1716.5 ± 218.8 1458.5 ± 283.16 1119.5 ± 226.8 1966.5** ± 458.7 
cl8 , ml/min. Kg t 10.19 ± 1.19 11.06 ± 0.968 7.86 ± 1.5 7.29 ± 1.11 
tValues are expressed as median ± median deviation {Median Deviation = I I X1 - Xm I) 
r, 
* significant at P ::;; 0.05 (using student t-test) 
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Antipyrine disposition in one rabbit taken as a representative of 
the group fed Helenium flexuosum; the decay is less steeper 




Antipyrine disposition is commonly employed as an indirect index for 
measurement of MFO system activity. Changes in the half-life of elimination 
and clearance of antipyrine are considered to provide an overall assessment of 
inhibition or induction of the MFO system (Vesell, 1979; Danhof & Teunissen, 
1984). 
In the present study, Helenium flexuosum prolonged markedly the half-
life of antipyrine elimination (ty,p) from a median of 99.5 min (control diet) to a 
median of 215.5 min (Helenium diet). The lengthening of ty,p and the 
concomitant decrease in P from a mean of 0.0067 min-1 to a mean of 0.0036 
min-1 is strongly indicative that Helenium flexuosum inhibits the MFO system. 
These findings corroborate the finding of Chapman et al. ( 1988) who reported 
that helenalin, a sesquiterpene lactone isolated from Helenium microcephalum, 
acts as an inhibitor of cytochrome P-450 and cytochrome b5, key enzymes in 
the MFO system. Furthermore, these in vivo results are in agreement with in 
vitro findings of Dalvi and McGowan (1982), who reported that incubation of 
helenin with microsomal proteins produced a profound loss of cytochrome P-
450 activity. These results are indicative of the potential for Helenium species 
to influence the disposition and biological effects of other chemicals to which 
the animal may be concurrently exposed. 
There were no significant changes in antipyrine pharmacokinetic 
parameters when rabbits were given Artemisia filifolia. However, in all six 
rabbits, there was a consistent shortening of antipyrine half-life of elimination. 
This consistent change was small and statistically insignificant but may have 
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been significant under different experimental conditions, such as a longer period 
of gavaging and/or more animals. 
In the present study, in order to avoid pharmacokinetic intraspecies 
variations reported in rabbits by Chambers and Jefferson ( 1 982) and by Paxton 
( 1 983), each rabbit was used to serve as its own control. Rabbits appear to be 
good animal models to assess the impact of xenobiotics in food, this could be 
attributed to the absence of hepatic vein sphincters, a criterion shared by 
Humans (Orszulak-Michalak and Kaszubski, 1987). The lack of hepatic vein 
sphincters would enable rabbits to have a consistent blood flow to the organ 
of biotransformation and elimination. 
The significant increase in Vd experienced after feeding Helenium 
flexuosum compared to the control diet was an unexpected finding. A similar 
change in volume of distribution of antipyrine in rabbits has been reported by 
Taylor and Houston ( 1 985) following promethazine pretreatment. The increase 
in Vd had counterpoised the decrease in P and thus prevented a change in Cl8 
which would have been evident had the V d not changed (Cl8 = PxV d). There 
is no ready explanation for this phenomenon but perhaps a reasonable 
conjecture would be that the toxic effects of· Helenium flexuosum delayed 
attainment of the distribution equilibrium. 
In conclusion, the results of our study showed that Helenium flexuosum 
exerted a marked influence on disposition of antipyrine presumably as a result 
of inhibition of the MFO system. Other plants available as food for range 
animals may also modify metabolism and pharmacokinetic parameters of drugs 
administered during consumption of these plants. Therefore, the type of food 
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CHAPTER IV 
EFFECTS OF ARTEMIS/A FIL/FOL/A AND HELEN/UM FLEXUOSUM COMPARED 
TO PHENOBARBITAL, 3 METHVLCHOLANTHRENE, AND SKF-525A 
ON ALKOXVRESORUFIN 0-DEALKVLATION 
BY RABBIT HEPATIC MICROSOMES 
INTRODUCTION 
It is well established that drugs and other xenobiotics, such as 
pesticides, food additives, cosmetic ingredients, environmental pollutants, and 
natural plant products enter the body and represent a potential threat to the 
health of the individual. These xenobiotics may be biotransformed to less toxic 
metabolites or activated to dangerous electrophiles that are detrimental to the 
host. In most instances, this is accomplished by a superfamily enzyme system 
called cytochrome P-450 (Guengrich, 1991 ). 
The cytochrome P-450 superfamily, the so-called "CYP" for human and 
"cyp" for mouse, exists in multiple forms of isoenzymes: at least 23 and 38 
isoenzymes have been characterized by genetic mapping in rabbits and rats, 
respectively (Nebert et al., 1991). Each P-450 isoenzyme possesses different 
but possibly overlapping catalytic activities. In the previous decade, 0-
dealkylation of alkoxyresorufin ethers has become accepted as an exceptionally 
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useful tool to differentiate isoenzymes within the cytochrome P-450 
superfamily. For instance, ethoxyresorufin has been reported to be a highly 
specific substrate for 3-methylcholanthrene (3MC)-inducible forms of 
cytochrome P-450, such as CYP1 A 1 and CYP1 A2; whereas pentoxyresorufin 
has been shown to be the substrate of choice for phenobarbital (PB)-inducible 
forms of cytochrome P-450, such as CYP2B1 and CYP2B2 (Burke and Mayer, 
1983; Lubet et al., 1985; Yang et al., 1988). 
Two plants, Artemisia filifolia and Helenium flexuosum, were evaluated 
in this experiment as they have been reported to contain sesquiterpene lactones 
with an exocyclic methylene group, a highly reactive moiety that can readily 
alkylate thiol-containing compounds by Michael-type addition (Herz, 1978; 
Appendino et al., 1982; Merrill et al., 1988). This property prompted us to 
hypothesize that metabolism of these plants might be mediated through 
cytochrome P-450, and thereby lead to alterations in its ability to catalyze 0-
dealkylation of alkoxyresorufin ethers. 
In the present experiments, we studied the 0-dealkylation of a series of 
alkoxyresorufin ethers by hepatic microsomes prepared from control and 
xenobiotic-treated rabbits in order to: 
1 . determine the ability of prototype P-450 inducers PB and 3MC and the 
prototype P-450 inhibitor proadifen hydrochloride (SKF-525A) to affect the level 
of hepatic cytochrome P-450 and consequently modulate the 0-dealkylation of 
alkoxyresorufin ethers. 
2. determine the effect of incorporating xenobiotics of plant origin in the diet 
such as Artemisia filifolia and Helenium flexuosum on hepatic cytochrome P-
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450 and on the ability of hepatic microsomes to dealkylate alkoxyresorufin 
ethers. 
3. Compare the specificity of alkoxyresorufin ethers for various prototype and 
non-prototype xenobiotics. 
MATERIALS AND METHODS 
Chemicals 
Phenobarbital (PB) was purchased from Elkins-Sinn, Inc. (Cherry Hill, NJ 
08003-4099). 3-methylcholanthrene (3MC) and NADPH were purchased from 
Sigma Chemical Co. (P.O. Box 14508, St. Louis, MO 63178). Proadifen 
hydrochloride (SKF-525A) was a generous gift from SmithKline Beecham 
Pharmaceuticals (P.O. Box 1539, King of Prussia, PA 19406). 
Methyl-, ethyl-, pentyl- and benzyloxyresorufin and standard resorufin 
were obtained from Molecular Probe Inc. (Junction City, OR 97448). 
Propoxyresorufin was synthesized in our laboratory according to the methods 
described by Elangbam et al. ( 1 991). 
Plants of Artemisia filifolia and Helenium flexuosum were collected from 
sites in western and eastern Oklahoma, respectively. They were air-dried, 
finely ground, and stored in plastic bags. 
Experimental Protocol 
Adult male New Zealand albino rabbits (n = 24) were caged individually 
in a controlled environment room under 12: 12 lighting schedule with rabbit 
chow (Acco) and water available ad libitum. Rabbits were allowed to acclimate 
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for a week before treatments were commenced. 
The experimental protocol was carried out in a quadrinomial manner. In 
each term, six rabbits were done at a time. Rabbit No. 1 was untreated and 
served as a control. Rabbit No. 2 was administered phenobarbital (PB) daily at 
a dose rate of 60 mg/kg i.p. for 5 days. Rabbit No. 3 was administered 3-meth-
ylcholanthrene (3MC) daily at a dose rate of 25 mg/kg i.p. for 5 days. Rabbit 
No. 4 was administered SKF-525A at a dose rate of 100 mg/kg i.p. just 1 hour 
before the animal was sacrificed. Rabbit No. 5 and Rabbit No. 6 were gavaged 
with Artemisia filifolia and Helenium flexuosum, respectively. The finely ground 
plants were packed in gelatin capsules and gavaged using a balling gun at a 
dose rate of 250 mg/kg daily for 5 consecutive days. 
Preparation of Liver Microsomes 
Microsomes were prepared from four individual animals per treatment. 
Animals were fasted overnight and euthanatized in the 6th day by CO2 
asphyxiation. Ten grams of each animal liver were immediately washed twice 
in cold 1.15% (w/v) KCI, minced, and homogenized in Tris-KCI buffer. 
Microsomes were harvested and total cytochrome P-450 was assayed using 
the method of Omura and Sato ( 1 964). Microsomal protein was estimated 
using the BCA protein assay (Smith et al., 1985). The resulting microsomal 
pellets were suspended in SET buffer (pH = 7.4) and stored in 0.2 ml aliquots 
at -135oC. 
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Analysis of Alkoxyresorufin Metabolism 
Assay of the 0-dealkylation of various alkoxyresorufin ethers to the 
common metabolite, resorufin, was carried out essentially as described by 
Burke et al. (1985). Incubations were performed directly in a 4.0 ml 
fluorometric cuvette at 37oC with the use of a Spex-FluroMax™1, and 
formation of the fluorescent metabolite, resorufin, was detected at wavelength 
settings of 540 nm and 585 nm for excitation and emission, respectively. 
Thirty microliter of 1 mM solution of the substrate, alkoxyresorufin, was 
mixed with 2700 µI of 0.1 M NalK phosphate buffer, pH 7.6 and microsomal 
protein was added in a volume of 140 µI. Total protein concentration was 
between 25 µg/ml and 103 µg/ml (i.e., protein concentration inside the cuvette 
was between 1.20 µg/ml and 4.95 µg/ml) depending on the inducing or 
inhibiting agent used in the experimental protocol. The baseline was recorded 
for 20 seconds, then dealkylation was initiated by the addition of 10 µI of 60 
mM NADPH (Sigma), and the reaction was allowed to proceed for 2 minutes 
to measure the slope generated by the increase in fluorescence due to 
formation of resorufin as a sequela of dealkylation. Calibration was then 
achieved by the addition of 30 µI 0.1 mM standard resorufin. 
Statistical Analysis 
The decision tree method was used to select the appropriate hypothesis-
testing procedure (Gad and Weil, 1988). Data were first subjected to Bartlett's 
1a Spex-FluroMax Industries, Inc., Edison, NJ USA. 
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test to detect homogeneity of variances; since the variances were homogenous 
ANOVA was used. As a result of a significant F-value, Dunnett's-test was 
carried out as a post-hoc to ANOVA to provide further intracomparison of 
groups vs. control without increasing Type I error. Results were considered 
significant at P < 0.05. 
RESULTS 
Phenobarbital (PB) and 3-methylcholanthrene (3MC) increased the total 
hepatic microsomal cytochrome P-450 content by 2 - 3 fold as compared to the 
control (table 1). 
PB-induced microsomes significantly increased the rate of 0-dealkylation 
of benzyloxyresorufin and pentoxyresorufin as compared to the control (table 
2). Benzyloxyresorufin was the substrate of choice showing the highest rate of 
metabolism (3537 pmole/min/mg) and the greatest degree of induction over 
control, approximately 47 fold (table 2 and figure 1 ). 
In contrast, 3MC-induced microsomes significantly increased the rate of 
0-dealkylation of all alkoxyresorufin substrates as compared to the control 
(table 2). Methoxyresorufin substrate showed the highest rate of metabolism 
(5633 pmole/min/mg) but not the greatest degree of induction over the control. 
The greatest degree of induction over the control in 3MC-induced microsomes 
was shown by pentoxyresorufin, approximately 8 fold, but its rate of 
metabolism was only 339 pmole/min/mg which means that the differential 
factor (DF) between methoxyresorufin and pentoxyresorufin in case of 3MC-
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induced microsomes was 16.6 times in favor of methoxyresorufin and the OF 
between methoxyresorufin and benzyloxyresorufin was 18.4 times in favor of 
methoxyresorufin (DF = substrate showing the highest rate of metabolism 
substrate showing the lesser rate of metabolism). 
The 3MC-induced microsomes showed higher activity for dealkylation of 
short-alkyl chain (C1 to C3) and as the number of carbon atoms in the alkyl 
chain increased, the propensity to dealkylate decreased. Therefore, the 
capability of 3MC-induced microsomes to dealkylate alkoxyresorufin ethers can 
be arranged in the following order: methoxy > ethoxy > propoxy > pentoxy 
> benzyloxy (table 2). 
SKF-525A had no affect on the total cytochrome P-450 content in the 
rabbit nor did it affect the rate of 0-dealkylation of alkoxyresorufin ethers (table 
1 , table 2, and figure 3). 
Microsomes prepared from rabbits that were fed Artemisia filifo/ia or 
Helenium flexuosum caused a dramatic decrease, approximately 50%, in the 
rate of 0-dealkylation of short-alkyl chain alkoxyresorufin ethers (table 2, figure 









EFFECT OF VARIOUS XENOBIOTICS (INCLUDING KNOWN INDUCERS 
OR INHIBITORS) ON THE LEVEL OF HEPATIC CYTOCHROME 
P-450 IN THE RABBIT 
Treatment Cytochrome P-450 
(nmole/mg of protein) 
Control (no treatment) 1.50 ± 0.248 
Phenobarbital (PB) 3.85 ± 0.06b 
3-Methycholanthrene (3MC) 3.94 ± 0.07b 
Proadifen hydrochloride (SKF-525A) 1.34 ± 0.058 
Artemisia filifolia 1.37 ± 0.338 
Helenium flexuosum 1.34 ± 0.328 
Values are expressed as means ± standard deviation. 
a,bMeans with the different superscripts differ (p < 0.05). 
Table 2. 
ALKOXYRESORUFIN 0-DEALKYLATION ACTIVITY IN RABBITS FOLLOWING 
ADMINISTRATION OF VARIOUS XENOBIOTICS. 
Treatment 0-dealkylation of alkoxyresorufin activity (pmole resorufin/min/mg protein) 
(n = 4) Dose Methoxy Ethoxy Propoxy Pentoxy 
Control --- 2001 + 319 3055 + 176 1073 + 74 41 ± 10 
Phenobarbital 60 mg/kg i.p. for 5 days 1617 ± 174 2630 ± 422 832 ± 194 688**±127 
(- 17) 
3 MC 25 mg/kg i.p. for 5 days 5633** ±697 4754** ±265 1658** ±62 339** ± 70 
(-2.8) (-1.55) (-1.54) (-8.0) 
SKF-525A 100 mg/kg i.p. 1 hour 1874 ±300 2791 +371 1147±221 40 ± 9 
before animal sacrifice 
Artemisia 250 mg/kg gavaged for 5 days 824 ** ± 160 1638** + 79 526** ± 41 35 ± 8 
filifolia 
Helenium 250 mg/kg gavaged for 5 days 1153**± 56 1856** 254 642** ± 140 45 ± 10 
f/exuosum 
* *Significantly different at p < 0.05 using Dunnett's-test. 
Values are expressed as means ± standard error of the mean for four animals per treatment. 
( - ) = Approximate folds of induction = (reaction rate with induced microsomes divided by reaction rate with control microsomes) 
= Underlined substrates depict the highest rate of 0-dealkylation for the specific treatment. 
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Methoxy Ethoxy Propoxy Pentoxy Benzyloxy 
Alkoxyresorufin Ethers 
Figure 1. Mean ± SEM of hepatic alkoxyresorufin 0-dealkylation activity in 
control rabbits • and after 5 days of phenobarbital (PB) pretreatment 0 
(n = 4). *, significantly different from control. 
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Methoxy Ethoxy Propoxy Pentoxy Benzyloxy 
Alkoxyresorufin Ethers 
Figure 2. Mean ± SEM of hepatic alkoxyresorufin 0-dealkylation activity in 
control rabbits • and after 5 days of 3-methylcholanthrene (3MC) 
























Methoxy Ethoxy Propoxy Pentoxy Benzyloxy 
Alkoxyresorufin Ethers 
Figure 3. Mean ± SEM of hepatic alkoxyresorufin 0-dealkylation activity in 
control rabbits • and after 1 hour of proadifen hydrochloride (SKF-525A) 
pretreatment ~ (n = 4). 




















Methoxy Ethoxy Propoxy Pentoxy Benzyloxy 
Alkoxyresorufin Ethers 
Figure 4. Mean ± SEM of hepatic alkoxyresorufin 0-dealkylation activity in 
control rabbits • and following 5 days of dietary exposure to Artemisia 
filifolia ~ (n =4) . *, significantly different from control. 
56 






" C 2400 
E 











Methoxy Ethoxy Propoxy Pentoxy Benzyloxy 
Alkoxyresorufin Ethers 
Figure 5. Mean ± SEM of hepatic alkoxyresorufin 0-dealkylation activity in 
control rabbits • and following 5 days of dietary exposure to Helenium 
flexuosum ~ (n =4). *, significantly different from control. 
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DISCUSSION 
In PB-pretreated rabbits there was a profound induction of 
benzyloxyresorufin 0-dealkylation, approximately 47 fold as compared to the 
control. In contrast, the degree of induction of pentoxyresorufin 0-dealkylation 
conferred by PB-pretreatment was moderate, approximately 17 fold as 
compared to the control. This finding indicates that benzyloxyresorufin is the 
best substrate to distinguish between PB-induced microsomes and other 
xenobiotic-induced microsomes in the rabbit. Furthermore, this finding is in 
good agreement with the recent study by Lu bet et al. ( 1990) who reported that 
the rate of 0-dealkylation of benzyloxyresorufin in PB-induced rabbit liver is 
consistently higher than the rate of 0-dealkylation of pentoxyresorufin. 
It is of interest to note that there are obvious species and interspecies 
variations in catalytic preferences of 0-dealkylation of alkoxyresorufin ethers. 
For example, pentoxyresorufin is typically used as the substrate of choice to 
differentiate PB-inducible forms of cytochrome P-450 in C57 /BL 10 mice (Burke 
and Mayer, 1983) as well as in Sprague-Dawley rats (Burke et al., 1985), 
Fischer rats (Lubet et al., 1985), and cotton rats (Novak and Qualls, 1989). 
Whereas, benzyloxyresorufin was reported to be the most appropriate substrate 
to distinguish PB-inducible forms of cytochrome P-450 in Wistar rats (Godden 
et al., 1987; Mayer et al., 1990). 
In the present study, the 3MC-induced microsomes produced a 
significant increase in the rate of 0-dealkylation of all alkoxyresorufin substrates 
tested. The folds of increase as compared to the control was in the following 
order: pentoxy = 8 fold, benzyloxy = 4 fold, methoxy = 2.8 fold, ethoxy = 
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1.55 fold, and propoxy = 1.54 fold. However, this does not necessarily 
indicate that pentoxy is the substrate of choice to differentiate 3MC-inducible 
microsomes since its rate of 0-dealkylation was only 339 pmole/min/mg 
whereas the rate of 0-dealkylation of methoxy was 5633 pmole/min/mg, i.e., 
1 6. 6 times, greater than pentoxy. Thus, based on having the highest 0-
dealkylation activity and consequently formation of the largest amount of 
resorufin as the substrates undergo 0-dealkylation, methoxyresorufin was 
selected as the substrate of choice to evaluate 3MC-inducible forms of 
cytochrome P-450 in the rabbit. In fact, all alkoxyresorufin ethers with short-
alkyl chain such as methoxy (C1 ), ethoxy (C2), and propoxy (C3) showed 
higher and faster rates of 0-dealkylation as opposed to those with long-alkyl 
chain such as pentoxy (C5) and benzyloxy (C7). This indicates that 
alkoxyresorufin ethers with short-alkyl chain are preferred as differential probes 
for 3MC-type of induction in spite of the fact that they did not show the 
greatest fold of induction as compared to the control. 
The reason for the relatively small folds of induction observed with 3MC 
pretreatment in rabbits may in some measure be attributed to the inherently 
high basal activity of control microsomes (untreated) in catalyzing dealkylation 
of short-alkyl chain alkoxyresorufin ethers. Dealkylation of short-alkyl chain 
alkoxyresorufin ethers by untreated rabbit microsomes is 10 times greater than 
dealkylation by untreated microsomes from other species. For example, in our 
laboratory, dealkylation of methoxyresorufin and ethoxyresorufin ethers by 
untreated rabbit microsomes was 2001 pmole and 3055 pmole, respectively. 
This is in contrast to dealkylation of methoxy and ethoxy by microsomes from 
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untreated cotton rats of 340 pmole and 290 pmole, respectively; or by 
microsomes from untreated Sprague-Dawley rats of 140 pmole and 1 30 pmole, 
respectively (Novak and Qualls, 1989). Similarly dealkylation of ethoxy-
resorufin in white-footed mice (Peromyscus /eucopus) was 250 pmole 
(Simmons and McKee, 1992). Thus, rabbits appear to have greater propensity 
to dealkylate short-alkyl chain as compared to rats or mice. 
In the present study, short-alkyl chain ethers such as methoxy, ethoxy, 
and propoxy appear to represent the most appropriate substrates for 
differentiation of 3MC-inducible forms of cytochrome P-450 in the rabbit. The 
selection of the preferred substrates 0-dealkylated by 3MC-induced microsomes 
was based on the rate of 0-dealkylation activity rather than on the number of 
folds of induction. According to order of magnitude: methoxy = 5633 pmole, 
ethoxy = 4754 pmole, and propoxy = 1658 pmole. Thus, methoxy is favored 
as a differential probe for 3MC type of induction in rabbits. Unfortunately, 
Lu bet et al. ( 1990) did not use 3MC in rabbits; therefore, there was no facet 
for comparison. However, they reported similar methoxyresorufin preferential 
0-dealkylation in 3MC-pretreated hamsters. In this respect, it is worthy to 
note, ethoxyresorufin has been reported to be the preferential substrate for 
3MC-inducible forms of cytochrome P-450 in rats and mice (Burke and Mayer, 
1983; Lubet et al., 1985; Burke et al., 1985). 
It is well documented that at least two forms of cytochrome P-450 are 
induced by 3MC; CYP1 A 1 and CYP1 A2. In the present study, it could be 
deduced that 3MC pretreatment in the rabbit resulted in induction of CYP1 A2 
at a greater rate than CYP1 A 1 since CYP1 A2 preferentially dealkylate 
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methoxyresorufin while CYP1 A 1 preferentially dealkylate ethoxyresorufin 
(Yang et al., 1988). 
An interesting observation in the present study was the insignificant 
reduction in total cytochrome P-450 as well as the negligible inhibition of 
alkoxyresorufin 0-dealkylation conferred by pretreatment of rabbits with SKF-
525A, a known potent inhibitor of PB-inducible forms of cytochrome P-450 in 
rats (Rossi et al., 1987). Although this finding was unexpected, it is consistent 
with the findings of Kato and Takayangi ( 1966) who showed that the potency 
of SKF-525A as an inhibitor in the rabbit is far less than in the rat. Moreover, 
Chambers and Jefferson ( 1982) reported a lack of SKF-525A effect on anti-
pyrine clearance in rabbits, unlike its effect in rats where a clear-cut impedance 
of antipyrine clearance took place. Changes in antipyrine half-life and clearance 
are considered to be an indirect index for the overall degree of inhibition or 
induction of cytochrome P-450 since the drug is totally metabolized by 
cytochrome P-450 (Vesell, 1979; Danhof and Teunissen, 1984). 
The consecutive daily administration of Artemisia filifolia or Helenium 
flexuosum at a dose rate of 250 mg/kg for 5 days in the diet (i.e., 1 % of the 
total diet) resulted in a significant decrease, approximately 50%, in hepatic 
microsomal 0-dealkylation activity of short-alkyl chain alkoxyresorufin sub-
strates, primarily methoxy, ethoxy, and propoxyresorufin (as shown in table 2, 
figure 4 and figure 5). This finding suggests that ingestion of these plants 
produces an inhibition of isozymes that are normally induced by 3MC. 
This study is unique in using plant xenobiotics as modulators of 
alkoxyresorufin ethers 0-dealkylation. The results suggest that natural plant 
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xenobiotics are capable of inhibiting specific isozymes of cytochrome P-450. 
Some of these isozymes may be responsible for activation of innocuous 
chemicals into harmful toxicants. In such instances, natural plant products 
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CHAPTER V 
SUMMARY AND CONCLUSION 
The literature is replete with evidence that dietary constituents represent 
an important determinant of the pharmacotoxicological activities of drugs and 
other xenobiotics. Animals continually ingest or are exposed to a variety of 
chemical compounds present in their food plants. These chemicals may act as 
inducers or inhibitors of the Mixed Function Oxidase System (MFO), a major 
enzymatic system that mediates biotransformation, and as such can lead to 
attenuation or amplification of biological responses to concurrently administered 
drugs. 
In the first experiment of this study, six white-face female sheep were 
pair fed Artemisia filifolia, Artemisia ludoviciana, or alfalfa in combination with 
grass hay and concentrates. Drug disposition effects during these test-dietary 
regimens were determined by administration of antipyrine and erythromycin in 
a crossover-type design. Serum concentrations of drugs were determined and 
subjected to pharmacokinetic analysis. Both species of Artemisia as well as 
alfalfa produced an inducing-type effect on Mixed Function Oxidase System 
(MFO) as reflected by the significant increase in antipyrine clearance and 
elimination. Thus, indicating the potential for such diets to increase the 
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metabolism of antipyrine. Conversely, there was little or no change in 
metabolism of erythromycin. The result of this study indicated that dietary 
constituents are not only capable of altering drug residence time in sheep but 
also indicated that the requisite biotransformation pathways for antipyrine and 
erythromycin are different. The latter finding was later proved to be the case 
when it was shown that antipyrine metabolism is mediated by the isozyme 
CYP2B whereas erythromycin metabolism is mediated by the isozyme CYP3A. 
In the second experiment of this study, twelve adult male New Zealand 
white rabbits were acclimated and maintained on commercial rabbit pellets 
(ACCO) for a week before treatment commenced. On day 1, all rabbits were 
given antipyrine 25 mg/kg i.v.. Beginning on day 14, six of the rabbits were 
given Artemisia filifolia at a daily dosage of 250 mg/kg for 5 days while the 
remaining six were given Helenium flexuosum at the same dosage schedule. 
Antipyrine administration was repeated in all rabbits on day 19. Serial blood 
samples were taken following each antipyrine administration and serum 
concentrations were determined and subjected to pharmacokinetic analysis. 
Feeding Helenium flexuosum in combination with the standard rabbit pellets 
resulted in a significant increase in antipyrine half-life of elimination, indicating 
that Helenium flexuosum ingestion exerts a typical inhibitory-type effect on 
MFO. Feeding Artemisia filifolia was not accompanied by a significant change 
in antipyrine pharmacokinetic parameters in rabbits. 
It is very intriguing to find that ingestion of Artemisia filifolia exerted a 
pronounced inducing-type effect on MFO in sheep but not in rabbits, as 
reflected by changes in antipyrine metabolism. This phenomenon may be 
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explained within the realm of interspecies variation in metabolism which has 
been well documented in the literature. For example, the major metabolite of 
sulphadimidine in horses is 5-hydroxysulphadimidine while in camels the major 
metabolite is N4-Acetylsulphadimidine. A further example illustrating inter-
species variation in metabolism is the metabolism of coumarin which has been 
found to be metabolized into 7-hydroxycoumarin in man, whereas in rats the 
predominant metabolite is 3-hydroxycoumarin. This explains why coumarin is 
effective in preventing dimethylbenzanthracene-induced breast tumors in rats 
but not in humans; 7-hydroxycoumarin, the major metabolite in humans, is 
inactive against dimethylbenzanthracene-induced neoplasia. 
In the third experiment of this study, the 0-dealkylation of a series of 
alkoxyresorufin ethers by hepatic microsomes prepared from control-fed rabbits 
and plant-fed rabbits, with either Artemisia or Helenium, were compared. In 
addition, prototype P-450 inducers such as phenobarbital and 3-methyl-
cholanthrene and the prototype P-450 inhibitor proadifen hydrochloride (SKF-
525A) were used to provide a wider facet for comparison between dealkylation 
conferred by hepatic microsomes prepared from plant-fed rabbits and 
dealkylation conferred by hepatic microsomes prepared from other xenobiotic-
pretreated rabbits. 
Pretreatment of rabbits with prototype P-450 inducers phenobarbital and 
3-methylcholanthrene increased the basal hepatic cytochrome P-450 content 
by 2-3 fold whereas pretreatment with either the prototype P-450 inhibitor 
proadifen hydrochloride (SKF-525A) or test-plants, Artemisia filifolia and 
Helenium flexuosum, had no effect on basal cytochrome P-450 content. 
68 
Phenobarbital-induced hepatic microsomes significantly increased the 
rate of 0-dealkylation of benzyloxyresorufin and pentoxyresorufin, approx-
imately 47 fold and 17 fold respectively. In contrast, 3-methylcholanthrene-
induced hepatic microsomes increased the rate of 0-dealkylation of all 
alkoxyresorufin substrates tested; preferentially dealkylating substrates with a 
short-alkyl chain. Dealkylation of the short-alkyl chain substrates conferred by 
3-methylcholanthrene pretreatment was in the following order of magnitude: 
methoxyresorufin > ethoxyresorufin > propoxyresorufin. 
The consecutive daily administration of Artemisia filifolia or Helenium 
flexuosum at a dose rate of 250 mg/kg for 5 days in the diet (i.e., 1 % of the 
total diet) resulted in a remarkably significant decrease in hepatic microsomal 
0-dealkylation activity of short-alkyl chain substrates. In particular, dealkylation 
of methoxy-, ethoxy-, and propoxyresorufin was inhibited by approximately 
50%. This finding suggests that ingestion of these plants produces an 
inhibition of the same isozymes that are induced by 3-methylcholanthrene. 
In recapitulation of the second and third experiment, feeding Helenium 
flexuosum to rabbits prolonged the sojourn of antipyrine in the body indicating 
an inhibitory-type effect on Mixed Function Oxidase (MFO) System. Similarly, 
the 0-dealkylation of short-alkylchain alkoxyresorufin ethers was inhibited by 
approximately 50%. With respect to the effects of feeding Artemisia filifolia, 
antipyrine disposition was not affected. However, the 0-dealkylation of short-
alkyl chain alkoxyresorufin ethers was remarkably inhibited. 
In order to ratiocinate the apparently opposed metabolic effects exerted 
by ingestion of the two plants, one must bear in mind that the two substrates 
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used as indices to monitor modulation of biotransformation are metabolized by 
different isozymes. Antipyrine is metabolized by the isozyme CYP2B whereas 
short-alkyl chain alkoxyresorufin ethers are metabolized by the isozymes 
CYP1 A 1 and CYP1 A2. Thus, it could be inferred that Artemisia filifolia exerted 
an inhibitory effect only on the two isozymes responsible from the 0-
dealkylation of short-alkyl chain alkoxyresorufin ethers whereas Helenium 
flexuosum exerted an inhibitory effect on all three isozymes, the one that is 
responsible from antipyrine metabolism as well as the two that are responsible 
from alkoxyresorufin 0-dealkylation. 
lsozyme substrate specificity may explain the discrepancy between the 
effects of the two plants on different substrates. It is also possible that the 
active principles in the two plants are different, albeit the fact that they belong 
to one family. This may warrant further research to isolate and characterize the 
active ingredients present in these two plants. 
It has become increasingly clear that the challenge of understanding the 
effects of the different dietary regimens on metabolism of different drugs is an 
extremely difficult challenge but with the increase in knowledge and research 
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